DANIEL PERALTA: Open Payments
NPI 1952990079 · TAOS, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,387 in 81 payments from 21 companies in 2025. Trend: 2023 $309 · 2024 $1,344 · 2025 $1,387
Food & beverage: $1,387
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $235 |
| PFIZER INC. | 14 | $232 |
| Novo Nordisk Inc | 13 | $227 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Lilly USA, LLC | 3 | $59 |
| Viatris Specialty LLC | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Astellas Pharma US Inc | 2 | $48 |
Products named: NURTEC ODT, REXULTI, QULIPTA, Ozempic, VRAYLAR, MOUNJARO, YUPELRI, Kerendia.
Industry payments across NM — which companies pay providers there.
